Key Points
- Major shareholder Jorey Chernett bought 80,000 shares on March 3 at $1.71 (≈$136,800), increasing his stake to 6,322,611 shares (~$10.8M); he also bought 30,000 shares on March 4 at $1.87.
- AirSculpt (AIRS) trades around $1.95 with a market cap of roughly $121M, a negative P/E and a one‑year range of $1.51–$12.00, while analysts have a consensus rating of "Reduce" and a $6 target.
AirSculpt Technologies, Inc. (NASDAQ:AIRS - Get Free Report) major shareholder Jorey Chernett acquired 80,000 shares of AirSculpt Technologies stock in a transaction on Tuesday, March 3rd. The stock was acquired at an average cost of $1.71 per share, for a total transaction of $136,800.00. Following the purchase, the insider owned 6,322,611 shares of the company's stock, valued at approximately $10,811,664.81. This represents a 1.28% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own 10% or more of a company's stock are required to disclose their transactions with the SEC.
Jorey Chernett also recently made the following trade(s):
- On Wednesday, March 4th, Jorey Chernett acquired 30,000 shares of AirSculpt Technologies stock. The stock was bought at an average price of $1.87 per share, with a total value of $56,100.00.
AirSculpt Technologies Price Performance
Shares of AIRS traded up $0.11 during mid-day trading on Thursday, hitting $1.95. 216,445 shares of the company traded hands, compared to its average volume of 1,181,786. The company has a current ratio of 0.51, a quick ratio of 0.51 and a debt-to-equity ratio of 0.63. The stock has a market capitalization of $121.45 million, a price-to-earnings ratio of -6.48 and a beta of 2.75. The business has a 50-day moving average of $2.21 and a 200 day moving average of $4.91. AirSculpt Technologies, Inc. has a one year low of $1.51 and a one year high of $12.00.
Hedge Funds Weigh In On AirSculpt Technologies
A number of hedge funds and other institutional investors have recently made changes to their positions in AIRS. Virtu Financial LLC bought a new stake in shares of AirSculpt Technologies in the 4th quarter valued at $30,000. Millennium Management LLC acquired a new position in AirSculpt Technologies in the fourth quarter valued at about $33,000. Aigen Investment Management LP bought a new stake in shares of AirSculpt Technologies in the fourth quarter worth about $36,000. Wells Fargo & Company MN increased its holdings in shares of AirSculpt Technologies by 49.9% in the fourth quarter. Wells Fargo & Company MN now owns 19,275 shares of the company's stock worth $38,000 after acquiring an additional 6,420 shares in the last quarter. Finally, BNP Paribas Financial Markets raised its position in shares of AirSculpt Technologies by 239.5% during the third quarter. BNP Paribas Financial Markets now owns 5,952 shares of the company's stock worth $48,000 after purchasing an additional 4,199 shares during the period. 91.54% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several equities research analysts have recently commented on the stock. Weiss Ratings reiterated a "sell (d-)" rating on shares of AirSculpt Technologies in a research report on Monday, December 29th. Leerink Partners reaffirmed a "market perform" rating and issued a $6.00 price objective on shares of AirSculpt Technologies in a research note on Tuesday, November 11th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, AirSculpt Technologies has a consensus rating of "Reduce" and a consensus target price of $6.00.
View Our Latest Stock Analysis on AirSculpt Technologies
AirSculpt Technologies Company Profile
(
Get Free Report)
AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company's flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.
Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
